Aeglea Biotherapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $501k | 30k | 16.76 |
| 2025-06-30 | $448k | 30k | 14.97 |
| 2025-03-31 | $383k | 24k | 16.14 |
| 2024-12-31 | $498k | 21k | 23.28 |
| 2024-09-30 | $592k | 20k | 29.41 |
| 2024-06-30 | $207k | 8.8k | 23.51 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors